Core Insights - The article highlights the strategic partnerships formed by Australian health company Homart during the 8th China International Import Expo (CIIE) to expand its market presence in China and globally [1][3][5]. Group 1: Strategic Partnerships - Homart signed a long-term strategic cooperation agreement with JD Health, focusing on flagship store operations, new product incubation, consumer education, and anti-counterfeiting traceability [3][5]. - A memorandum of understanding was signed with AliExpress to enhance cross-border e-commerce, global marketing, and digital retail [5][7]. Group 2: Market Expansion Goals - The initial product launch will include approximately 40 SKUs from brands such as SpringLeaf and TopLife, with plans to expand to 200 SKUs within three years, targeting a cumulative sales goal of AUD 30 million [7]. - Homart aims to establish a global presence while focusing on the Chinese market as a core area for growth, with plans for an IPO on the Australian Securities Exchange (ASX) by 2026 [5][8]. Group 3: Vision and Future Plans - The CEO of Homart emphasized the importance of CIIE as a platform for showcasing and facilitating cooperation, aiming to bring more high-quality Australian products to China and the world [8]. - The company plans to strengthen strategic collaborations with partners in China and globally to create a more open, innovative, and sustainable global health industry ecosystem [8].